| Mr James C Abshire, LPC | |
|
219 Dothan Rd, Abbeville, AL 36310-2836 | |
| (334) 585-5331 | |
| (334) 585-5965 |
| Full Name | Mr James C Abshire |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 219 Dothan Rd, Abbeville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053479584 | NPI | - | NPPES |
| 51043903 | Other | AL | BLUE CROSS AND BLUE SHIEL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 2020 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James C Abshire, LPC 1841 Honeysuckle Rd, Dothan, AL 36305-4269 Ph: (334) 712-1170 | Mr James C Abshire, LPC 219 Dothan Rd, Abbeville, AL 36310-2836 Ph: (334) 585-5331 |
News Archive
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.
According to a team of researchers at the University of Cambridge and the National Institutes of Health (NIH), USA, a novel and comparatively simple technique that maps the wiring of the brain has indicated a relationship between how well connected a person's brain regions are and their intelligence.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
Virginia Commonwealth University researchers have identified a new tumor-promoting gene that may play a key role in the development of liver cancer. Levels of the gene's expression are significantly higher in more than 90 percent of patients with the disease compared to their healthy counterparts.
› Verified 7 days ago
Martina Nicole Rogers, Counselor Medicare: Not Enrolled in Medicare Practice Location: 430 Ozark Rd, Abbeville, AL 36310 Phone: 334-797-9131 | |
Shelina Marie Green, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 300 N Doswell St, Abbeville, AL 36310 Phone: 334-441-6526 | |
Robbie Treadwell, LPC Counselor Medicare: Medicare Enrolled Practice Location: 1242 Us Highway 431 S, Abbeville, AL 36310 Phone: 334-585-6864 Fax: 334-575-5216 |